The degradation of cellular molecules is a normal process that can go awry. Defects in the degradation of various cell macromolecules cause disease and are usually the result of mutations in specific enzymes. Two key enzymes in the degradation of cellular carbohydrates are alpha-N-acetylgalactosaminidase and alpha-galactosidase. Mutations in these enzymes cause Shindler and Fabry diseases, respectively. We have determined the structure of alpha-N-acetylgalactosaminidase by x-ray diffraction techniques and have constructed a model of the closely-related alpha-galactosidase enzyme. We have mapped the locations of mutations that give rise to Shindler and Fabry diseases and have begun to describe the catalytic mechanisms by which the enzymes perform their normal function of carbohydrate degradation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000901-03
Application #
6809305
Study Section
(LIG)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Garman, Scott C; Garboczi, David N (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337:319-35
Garman, Scott C; Hannick, Linda; Zhu, Alex et al. (2002) The 1.9 A structure of alpha-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases. Structure 10:425-34
Garman, Scott C; Garboczi, David N (2002) Structural basis of Fabry disease. Mol Genet Metab 77:3-11